Surgical treatment of multi-drug resistant pulmonary tuberculosis in children


  • M. S. Opanasenko SI «Yanovskyi National Institute of Phthisiology and Pulmonology of NAMS of Ukraine», Kyiv, Ukraine
  • O. V. Tereshkovych SI «Yanovskyi National Institute of Phthisiology and Pulmonology of NAMS of Ukraine», Kyiv, Ukraine



multiresistant tuberculosis, surgical treatment, children


Multi-drug-resistant tuberculosis (MRTB) of the lungs is the most pressing problem of modern phthisiology in Ukraine. Surgical treatment allows to improve the results of treatment of children with MRTB.

Objective: to acquaint a wide range of physicians with experience in the surgical treatment of children and adolescents with MRTB.

Material and methods. During the period from 2008 to 2018, the surgical treatment of pulmonary MRTB was performed in 24 children.

Results. The overall surgical treatment efficacy in the observation period up to 10 years made up 95.8%. The abacillation of bacillary excretion, the clinical condition improvement, cavity closure and positive X-ray picture in dynamics were observed in 23 (93.5%) patients. Postoperative complications were observed in 4 (16.7%) patients treated conservatively. Relapse of MRTB in the postoperative period was observed in 1 (4.2%) patient.

Conclusions. Comprehensive surgical treatment allows to improve the treatment outcomes of children with pulmonary MRTB.


Bai L, Hong Z, Gong C et al. (2013). Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. Eur J Cardiothorac Surg. PMid:22573718

D’Ambrosio L, Centis R, Tiberi S et al. (2017, Jul). Delamanid and bedaquiline to treat multidrug-resistant and extensively drugresistant tuberculosis in children: a systematic review. J Thorac Dis. 9(7): 2093–2101.; PMid:28840010 PMCid:PMC5542985

Dewan RK, Pezzella AT. (2016, Oct). Surgical aspects of pulmonary tuberculosis: an update. Asian Cardiovasc Thorac Ann. 24 (8):835–846.; PMid:27471312

Dheda K, Gumbo T, Maartens G et al. (2017). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrugresistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med.

Galli L, Lancella L, Garazzino S et al. (2016). Recommendations for treating children with drug-resistant tuberculosis. Italian Pediatric TB Study Group. Pharmacol Res. 105: 176–82.; PMid:26821118

Harausz EP, Garcia-Prats AJ, Seddon JA et al. (2017). New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. Am J Respir Crit Care Med. 195(10): 1300–1310.; PMid:27854508

Harris RC, Khan MS, Martin LJ et al. (2016). The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 16: 262.;

Klotz LV, Lindner M, Hatz RA. (2015). Pulmonary Tuberculosis — Is Surgery still Necessary? Zentralbl Chir. 1: 36–42.

Kumari M, Shah I. (2017). Need for Revision of Guidelines for Management of DR-TB in Children. Indian Pediatr. 54(2): 164–165. PMid:28285302

Marfina GY, Vladimirov KB, Avetisian AO et al. (2018). Bilateral cavitary multidrug- or extensively drug-resistant tuberculosis: role of surgery. Eur J Cardiothorac Surg. 53(3): 618–624.; PMid:29040413

Ots ON, Agkatsev TV, Perel’man MI. (2009). Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs. Probl Tuberk Bolezn Legk. (2): 42–9. PMid:19382642

Wang L, Xia F, Li F et al. (2018, Mar 1). Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series. Eur J Cardiothorac Surg. 53(3): 618–624



Original articles. Thoracic surgery